{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:58:46Z","timestamp":1792205926737,"version":"4.4.0"},"reference-count":382,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2023M743201"],"award-info":[{"award-number":["2023M743201"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZB20230671"],"award-info":[{"award-number":["GZB20230671"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403461"],"award-info":[{"award-number":["82403461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.drup.2025.101273","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:22:00Z","timestamp":1751426520000},"page":"101273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors"],"prefix":"10.1016","volume":"82","author":[{"given":"Xinhao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7378-7931","authenticated-orcid":false,"given":"Shuaixi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101273_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101273_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","article-title":"Applications of single-cell sequencing in cancer research: progress and perspectives","volume":"14","author":"Lei","year":"2021","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101273_bib3","article-title":"Single-cell spatial landscapes of the lung tumour immune microenvironment","volume":"614","author":"M","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101273_bib4","doi-asserted-by":"crossref","first-page":"1403122","DOI":"10.3389\/fcell.2024.1403122","article-title":"Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance","volume":"12","author":"Kazakova","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.drup.2025.101273_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"De Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101273_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101273_bib9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","article-title":"Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance","volume":"18","author":"Fiori","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41419-023-06060-z","article-title":"Cancer-associated fibroblasts: tumor defenders in radiation therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101273_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13046-022-02524-w","article-title":"The importance of being CAFs (in cancer resistance to targeted therapies)","volume":"41","author":"Rizzolio","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.trecan.2022.03.001","article-title":"Targeting CAFs to overcome anticancer therapeutic resistance","volume":"8","author":"Saw","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib13","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101273_bib14","doi-asserted-by":"crossref","first-page":"46662","DOI":"10.1038\/srep46662","article-title":"CD200-positive cancer associated fibroblasts augment the sensitivity of epidermal growth factor receptor mutation-positive lung adenocarcinomas to EGFR tyrosine kinase inhibitors","volume":"7","author":"Ishibashi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2025.101273_bib15","article-title":"Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer","volume":"68","author":"Qu","year":"2023","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2025.101273_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216234","article-title":"Cancer-associated fibroblasts: key criminals of tumor pre-metastatic niche","volume":"566","author":"Dong","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.trecan.2024.11.005","article-title":"Functional heterogeneity of fibroblasts in primary tumors and metastases","volume":"11","author":"Cheng","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib18","article-title":"Comprehensive single-cell analysis reveals heterogeneity of fibroblast subpopulations in ovarian cancer tissue microenvironment","volume":"10","author":"B","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.drup.2025.101273_bib19","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","article-title":"Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer","volume":"12","author":"McAndrews","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101273_bib20","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","article-title":"Fibroblasts in cancer: unity in heterogeneity","volume":"186","author":"Chhabra","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101273_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer\u2011associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114504","article-title":"Cancer-associated fibroblasts: origin, function, imaging, and therapeutic targeting","volume":"189","author":"Rimal","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drup.2025.101273_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.drup.2025.101273_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101273_bib25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","article-title":"A single-cell landscape of high-grade serous ovarian cancer","volume":"26","author":"Izar","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2025.101273_bib26","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101273_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41421-022-00445-8","article-title":"Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.drup.2025.101273_bib28","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.3390\/ijms22094960","article-title":"The blockade of tumoral IL1\u03b2-mediated signaling in normal colonic fibroblasts sensitizes tumor cells to chemotherapy and prevents inflammatory CAF activation","volume":"22","author":"D\u00edaz-Maroto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101273_bib29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ajpath.2024.03.012","article-title":"Modulating PCGF4\/BMI1 stability is an efficient metastasis-regulatory strategy used by distinct subtypes of cancer-associated fibroblasts in intrahepatic cholangiocarcinoma","volume":"194","author":"Hu","year":"2024","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drup.2025.101273_bib30","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","article-title":"Classifying cancer-associated fibroblasts-The good, the bad, and the target","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","article-title":"Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications","volume":"72","author":"Martin-Serrano","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.drup.2025.101273_bib32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib33","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"Zhang","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drup.2025.101273_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib35","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.ccell.2022.09.015","article-title":"Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin","volume":"40","author":"Foster","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib37","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drup.2025.101273_bib38","article-title":"Transcriptome landscape of cancer-associated fibroblasts in human PDAC","volume":"12","author":"Tao","year":"2025","journal-title":"Adv. Sci. Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.drup.2025.101273_bib39","doi-asserted-by":"crossref","first-page":"eado0173","DOI":"10.1126\/sciadv.ado0173","article-title":"Fibroblast atlas: shared and specific cell types across tissues","volume":"11","author":"Liu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2025.101273_bib40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41416-024-02734-3","article-title":"Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade","volume":"131","author":"Owaki","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216095","article-title":"PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells","volume":"558","author":"Ge","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","article-title":"Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.drup.2025.101273_bib43","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011648","article-title":"FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma","volume":"13","author":"Xu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib45","article-title":"Cancer-associated fibroblasts derived amphiregulin promotes HNSCC progression and drug resistance of EGFR inhibitor","author":"Zhou","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib46","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s43587-025-00842-0","article-title":"Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer","volume":"5","author":"Cheng","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.drup.2025.101273_bib47","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1016\/j.csbj.2022.11.025","article-title":"Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers","volume":"20","author":"Zhao","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.drup.2025.101273_bib48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41467-018-03348-z","article-title":"miR200-regulated CXCL12\u03b2 promotes fibroblast heterogeneity and immunosuppression in ovarian cancers","volume":"9","author":"Givel","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib49","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101273_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.100975","article-title":"Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis","volume":"14","author":"Cheng","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.drup.2025.101273_bib51","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","article-title":"Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing","volume":"9","author":"Bartoschek","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10+GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101273_bib53","doi-asserted-by":"crossref","first-page":"eadj5705","DOI":"10.1126\/scitranslmed.adj5705","article-title":"TSPAN8+ myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer","volume":"16","author":"Fan","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib54","article-title":"Dissecting the spatial and single-cell transcriptomic architecture of cancer stem cell niche driving tumor progression in gastric cancer","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.drup.2025.101273_bib55","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12967-025-06376-8","article-title":"Single-cell RNA sequencing and spatial transcriptomics reveal the heterogeneity and intercellular communication of cancer-associated fibroblasts in gastric cancer","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib56","article-title":"Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer","volume":"12","author":"X","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101273_bib57","first-page":"12","article-title":"Decorin as a key marker of desmoplastic cancer-associated fibroblasts mediating first-line immune checkpoint blockade resistance in metastatic gastric cancer","volume":"28","author":"Kim","year":"2025","journal-title":"Gastric Cancer Off. J. Int. Gastric Cancer Assoc. Jpn. Gastric Cancer Assoc."},{"key":"10.1016\/j.drup.2025.101273_bib58","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.3818","article-title":"Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors","volume":"49","author":"Li","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drup.2025.101273_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13059-022-02677-z","article-title":"Refining colorectal cancer classification and clinical stratification through a single-cell atlas","volume":"23","author":"Khaliq","year":"2022","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2025.101273_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70281","article-title":"Transitional CXCL14+ cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma","volume":"15","author":"Xu","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib61","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.ccell.2021.09.003","article-title":"Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms","volume":"39","author":"Hu","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib62","article-title":"Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures","volume":"6","author":"Peyraud","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.drup.2025.101273_bib63","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype molding of stromal cells in the lung tumor microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2025.101273_bib64","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/s41388-025-03318-y","article-title":"Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1\/glycolysis\/H3K18la positive feedback loop","volume":"44","author":"Zhang","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib65","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/0008-5472.CAN-24-1185","article-title":"Hypoxia-induced senescent fibroblasts secrete IGF1 to promote cancer stemness in esophageal squamous cell carcinoma","volume":"85","author":"Ou","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib66","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1038\/s41467-021-27599-5","article-title":"Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment","volume":"12","author":"Dinh","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib67","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1038\/s41467-021-25539-x","article-title":"Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib68","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in esophageal squamous cell carcinoma","volume":"10","author":"Jia","year":"2023","journal-title":"Adv. Sci. Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.drup.2025.101273_bib69","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1158\/1078-0432.CCR-20-4226","article-title":"Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis, prognosis, and immunotherapy resistance","volume":"27","author":"Galbo","year":"2021","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13058-022-01543-x","article-title":"High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patients","volume":"24","author":"Al-Tweigeri","year":"2022","journal-title":"Breast Cancer Res. BCR"},{"key":"10.1016\/j.drup.2025.101273_bib71","article-title":"A CD10-OGP membrane peptolytic signaling axis in fibroblasts regulates lipid metabolism of cancer stem cells via SCD1","volume":"8","author":"Yu","year":"2021","journal-title":"Adv. Sci. Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.drup.2025.101273_bib72","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s12885-023-11011-0","article-title":"FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib73","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ccell.2022.10.015","article-title":"CD16+ fibroblasts foster a trastuzumab-refractory microenvironment that is reversed by VAV2 inhibition","volume":"40","author":"Liu","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib74","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/jcmm.13118","article-title":"CD44+ fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling","volume":"21","author":"Liu","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2025.101273_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216747","article-title":"CD63+ cancer-associated fibroblasts confer CDK4\/6 inhibitor resistance to breast cancer cells by exosomal miR-20","volume":"588","author":"Sun","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib76","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/1078-0432.CCR-15-2851","article-title":"Fibroblast subtypes regulate responsiveness of luminal breast cancer to estrogen","volume":"23","author":"Brechbuhl","year":"2017","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib77","doi-asserted-by":"crossref","first-page":"16178","DOI":"10.18632\/aging.203145","article-title":"GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ER\u03b1-positive breast cancer cells","volume":"13","author":"L","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.drup.2025.101273_bib78","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/onc.2016.370","article-title":"Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP\/PKA\/CREB\/glycolytic axis to confer tumor cells with multidrug resistance","volume":"36","author":"Yu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib79","article-title":"PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity","volume":"68","author":"R","year":"2023","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2025.101273_bib80","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41388-021-01906-2","article-title":"A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers","volume":"40","author":"Hamalian","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009877","article-title":"AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization","volume":"12","author":"Liu","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib82","doi-asserted-by":"crossref","first-page":"12674","DOI":"10.18632\/aging.205205","article-title":"Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC","volume":"15","author":"Wu","year":"2023","journal-title":"Aging"},{"key":"10.1016\/j.drup.2025.101273_bib83","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1158\/1078-0432.CCR-14-0846","article-title":"Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation","volume":"21","author":"Yoshida","year":"2015","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70025","article-title":"IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer","volume":"28","author":"Wu","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2025.101273_bib85","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/cjp2.333","article-title":"Cancer-associated fibroblast expression of glutamine fructose-6-phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer","volume":"9","author":"Yang","year":"2023","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.drup.2025.101273_bib86","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-17-2928","article-title":"GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma","volume":"78","author":"Zhang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib87","article-title":"Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC","volume":"181","author":"Heenatigala Palliyage","year":"2023","journal-title":"Lung Cancer Amst. Neth."},{"key":"10.1016\/j.drup.2025.101273_bib88","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00109-023-02384-7","article-title":"Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer","volume":"101","author":"Takatsu","year":"2023","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"10.1016\/j.drup.2025.101273_bib89","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1158\/1078-0432.CCR-14-3111","article-title":"Upregulation of periostin and reactive stroma is associated with primary chemoresistance and predicts clinical outcomes in epithelial ovarian cancer","volume":"21","author":"Ryner","year":"2015","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib90","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101273_bib91","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","article-title":"LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity","volume":"611","author":"Krishnamurty","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101273_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12575-024-00254-1","article-title":"Metabolic and immunological implications of MME+CAF-mediated hypoxia signaling in pancreatic cancer progression: therapeutic insights and translational opportunities","volume":"26","author":"Wang","year":"2024","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.drup.2025.101273_bib93","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1053\/j.gastro.2020.11.044","article-title":"Cadherin 11 promotes immunosuppression and extracellular matrix deposition to support growth of pancreatic tumors and resistance to gemcitabine in mice","volume":"160","author":"Peran","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2025.101273_bib94","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/0008-5472.CAN-17-1366","article-title":"Tumor-stroma IL1\u03b2-IRAK4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer","volume":"78","author":"Zhang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib95","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/s41388-023-02711-9","article-title":"Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix","volume":"42","author":"Duan","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib96","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-20-0775","article-title":"Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast-driven nutritional support and immunosuppression","volume":"11","author":"Francescone","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101273_bib97","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/2767-9764.CRC-21-0147","article-title":"NetrinG1+ cancer-associated fibroblasts generate unique extracellular vesicles that support the survival of pancreatic cancer cells under nutritional stress","volume":"2","author":"Raghavan","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib98","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1016\/j.cell.2021.07.020","article-title":"Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy","volume":"184","author":"Koikawa","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101273_bib99","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ymthe.2025.01.023","article-title":"Pancreatic cancer-derived extracellular vesicles enhance chemoresistance by delivering KRASG12D protein to cancer-associated fibroblasts","volume":"33","author":"Liu","year":"2025","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.drup.2025.101273_bib100","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ccell.2023.05.016","article-title":"Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib101","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cac2.12414","article-title":"Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib","volume":"43","author":"Eun","year":"2023","journal-title":"Cancer Commun. Lond. Engl."},{"key":"10.1016\/j.drup.2025.101273_bib102","article-title":"Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.drup.2025.101273_bib103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41392-023-01728-6","article-title":"AKT2S128\/CCT\u03b1S315\/319\/323-positive cancer-associated fibroblasts (CAFs) mediate focal adhesion kinase (FAK) inhibitors resistance via secreting phosphatidylcholines (PCs)","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101273_bib104","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307914120","article-title":"Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma","volume":"120","author":"Liu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2025.101273_bib105","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41419-018-0808-2","article-title":"Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance","volume":"9","author":"Che","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101273_bib106","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1111\/jcmm.14205","article-title":"Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts","volume":"23","author":"Masuda","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2025.101273_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2022.11.005","article-title":"Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer","volume":"115","author":"Y","year":"2023","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.drup.2025.101273_bib108","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1186\/s12967-024-05939-5","article-title":"C3+ cancer-associated fibroblasts promote tumor growth and therapeutic resistance in gastric cancer via activation of the NF-\u03baB signaling pathway","volume":"22","author":"Zhao","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib109","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5230\/jgc.2024.24.e25","article-title":"Galectin-1 promotes gastric carcinoma progression and cisplatin resistance through the NRP-1\/c-JUN\/Wee1 pathway","volume":"24","author":"Pan","year":"2024","journal-title":"J. Gastric Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib110","article-title":"Single cell and bulk RNA sequencing identifies tumor microenvironment subtypes and chemoresistance-related IGF1+ cancer-associated fibroblast in gastric cancer","volume":"1870","author":"X","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.drup.2025.101273_bib111","first-page":"503","article-title":"CAF promotes chemoresistance through NRP2 in gastric cancer","volume":"25","author":"Yang","year":"2022","journal-title":"Gastric Cancer Off. J. Int. Gastric Cancer Assoc. Jpn. Gastric Cancer Assoc."},{"key":"10.1016\/j.drup.2025.101273_bib112","article-title":"PPIC-labeled CAFs: key players in neoadjuvant chemotherapy resistance for gastric cancer","volume":"48","author":"H","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.drup.2025.101273_bib113","volume":"166","author":"Zhang","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.drup.2025.101273_bib114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12935-019-0844-8","article-title":"Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer","volume":"19","author":"Ma","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.drup.2025.101273_bib115","article-title":"SNAI1-expressing fibroblasts and derived-extracellular matrix as mediators of drug resistance in colorectal cancer patients","volume":"450","author":"C","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.drup.2025.101273_bib116","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1158\/0008-5472.CAN-23-3987","article-title":"Cancer-associated fibroblasts expressing sulfatase 1 facilitate VEGFA-dependent microenvironmental remodeling to support colorectal cancer","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib117","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12943-024-02180-y","article-title":"THBS2\u2009+\u2009cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K\/AKT activation in colorectal cancer","volume":"23","author":"Zhou","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib118","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41419-019-1493-5","article-title":"TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer","volume":"10","author":"Izumi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101273_bib119","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009281","article-title":"NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer","volume":"12","author":"Yang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib120","article-title":"Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer","author":"Xiong","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.drup.2025.101273_bib121","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1158\/1078-0432.CCR-20-2915","article-title":"Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer","volume":"27","author":"Guardia","year":"2021","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib122","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ccell.2020.06.005","article-title":"Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer","volume":"38","author":"Zhang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib123","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41467-024-45595-3","article-title":"Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway","volume":"15","author":"Licaj","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib124","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib125","first-page":"347","article-title":"Transcription factors in fibroblast plasticity and CAF heterogeneity","volume":"42","author":"Melchionna","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2025.101273_bib126","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib127","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-17-0148","article-title":"JAK1\/STAT3 activation through a proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung cancer","volume":"16","author":"Shien","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2025.101273_bib128","first-page":"1482","article-title":"IL-6 secreted from cancer-associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial-mesenchymal transition signaling","volume":"11","author":"Shintani","year":"2016","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib129","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20160855","article-title":"An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition","volume":"214","author":"Young","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drup.2025.101273_bib130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1158\/0008-5472.CAN-23-0104","article-title":"Autotaxin secretion is a stromal mechanism of adaptive resistance to TGF\u03b2 inhibition in pancreatic ductal adenocarcinoma","volume":"84","author":"Pietrobono","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib131","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib132","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210815","article-title":"Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts","volume":"219","author":"Kerdidani","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drup.2025.101273_bib133","article-title":"Interferon-\u03b3-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer","volume":"6","author":"Cao","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.drup.2025.101273_bib134","article-title":"Single-cell analysis reveals transcriptomic features of drug-tolerant persisters and stromal adaptation in a patient-derived EGFR-mutated lung adenocarcinoma xenograft model","volume":"18","author":"N","year":"2023","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40364-024-00656-z","article-title":"Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma","volume":"12","author":"Jiang","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.drup.2025.101273_bib136","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccell.2022.01.004","article-title":"Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer","volume":"40","author":"Nicolas","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib137","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib138","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/cac2.12295","article-title":"Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: emerging avenue for targeted therapy","volume":"42","author":"Bhat","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.drup.2025.101273_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217272","article-title":"Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma","volume":"604","author":"Huang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib140","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/onc.2017.387","article-title":"IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma","volume":"37","author":"Qiao","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib141","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41420-020-0272-5","article-title":"Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells","volume":"6","author":"Cheteh","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.drup.2025.101273_bib142","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2019.04.002","article-title":"Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer","volume":"454","author":"Zhai","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib143","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1038\/s41467-021-24687-4","article-title":"Stromal induction of BRD4 phosphorylation results in chromatin remodeling and BET inhibitor resistance in colorectal cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib144","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41401-022-00927-1","article-title":"Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K\/akt signaling","volume":"44","author":"Zhao","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.drup.2025.101273_bib145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12964-024-01550-9","article-title":"CD146+CAFs promote progression of endometrial cancer by inducing angiogenesis and vasculogenic mimicry via IL-10\/JAK1\/STAT3 pathway","volume":"22","author":"Yu","year":"2024","journal-title":"Cell Commun. Signal. CCS"},{"key":"10.1016\/j.drup.2025.101273_bib146","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4143\/crt.2018.031","article-title":"Cancer-associated fibroblasts promote the chemo-resistance in gastric cancer through secreting IL-11 targeting JAK\/STAT3\/Bcl2 pathway","volume":"51","author":"Ma","year":"2019","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.drup.2025.101273_bib147","doi-asserted-by":"crossref","first-page":"38408","DOI":"10.1038\/srep38408","article-title":"Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11\/IL-11R\/STAT3 signaling pathway","volume":"6","author":"Tao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2025.101273_bib148","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nm.3291","article-title":"An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy","volume":"19","author":"Chung","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2025.101273_bib149","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1084\/jem.20131195","article-title":"Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A","volume":"210","author":"Lotti","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drup.2025.101273_bib150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41419-025-07624-x","article-title":"Interleukin-33 (IL-33) promotes DNA damage-resistance in lung cancer","volume":"16","author":"Luo","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101273_bib151","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-19-0507","article-title":"Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma","volume":"8","author":"Xiang","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.drup.2025.101273_bib152","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41698-021-00189-w","article-title":"PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer","volume":"5","author":"Li","year":"2021","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.drup.2025.101273_bib153","article-title":"Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K\/akt signaling pathways","volume":"48","author":"B","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.drup.2025.101273_bib154","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1158\/2159-8290.CD-22-1046","article-title":"Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer","volume":"13","author":"A","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101273_bib155","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.neo.2016.08.002","article-title":"CXCL1-mediated interaction of cancer cells with tumor-associated macrophages and cancer-associated fibroblasts promotes tumor progression in human bladder cancer","volume":"18","author":"Miyake","year":"2016","journal-title":"Neoplasia N. Y. N."},{"key":"10.1016\/j.drup.2025.101273_bib156","article-title":"CXCL3\/TGF-\u03b2-mediated crosstalk between CAFs and tumor cells augments RCC progression and sunitinib resistance","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.drup.2025.101273_bib157","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/ijc.32278","article-title":"Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5","volume":"145","author":"Li","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib158","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009111","article-title":"Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8+ T cell infiltration","volume":"12","author":"Gan","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib159","first-page":"1606","article-title":"Cancer-associated fibroblasts contribute to cancer metastasis and apoptosis resistance in human ovarian cancer via paracrine SDF-1\u03b1","volume":"25","author":"Dai","year":"2023","journal-title":"Clin. Transl. Oncol. Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex."},{"key":"10.1016\/j.drup.2025.101273_bib160","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jid.2020.06.034","article-title":"Cancer-associated fibroblasts in mycosis fungoides promote tumor cell migration and drug resistance through CXCL12\/CXCR4","volume":"141","author":"Aronovich","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.drup.2025.101273_bib161","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1186\/s12885-023-11613-8","article-title":"Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12\/FOLR1","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib162","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41419-018-1104-x","article-title":"Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1\/SATB-1 pathway in pancreatic cancer","volume":"9","author":"Wei","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101273_bib163","doi-asserted-by":"crossref","first-page":"39559","DOI":"10.18632\/oncotarget.17136","article-title":"Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101273_bib164","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","article-title":"Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas","volume":"15","author":"Broz","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.653","article-title":"Cancer-associated fibroblast-derived colony-stimulating factor 2 confers acquired osimertinib resistance in lung adenocarcinoma via promoting ribosome biosynthesis","volume":"5","author":"Huang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.drup.2025.101273_bib166","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11418-023-01722-w","article-title":"Polysaccharides from Lentinus edodes prevent acquired drug resistance to docetaxel in prostate cancer cells by decreasing the TGF-\u03b21 secretion of cancer-associated fibroblasts","volume":"77","author":"Zhang","year":"2023","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.drup.2025.101273_bib167","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3390\/cancers12061393","article-title":"Anti-EGFR therapy induces EGF secretion by cancer-associated fibroblasts to confer colorectal cancer chemoresistance","volume":"12","author":"Garvey","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2025.101273_bib168","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1158\/1078-0432.CCR-19-0353","article-title":"Tumor-associated fibroblasts promote HER2-targeted therapy resistance through FGFR2 activation","volume":"26","author":"Fern\u00e1ndez-Nogueira","year":"2020","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib169","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1158\/1078-0432.CCR-11-2972","article-title":"Paracrine receptor activation by microenvironment triggers bypass survival signals and ALK inhibitor resistance in EML4-ALK lung cancer cells","volume":"18","author":"Yamada","year":"2012","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"793\u2013803","key":"10.1016\/j.drup.2025.101273_bib170","article-title":"Cancer-associated fibroblasts promote epithelial-mesenchymal transition and EGFR-TKI resistance of non-small cell lung cancers via HGF\/IGF-1\/ANXA2 signaling","volume":"1864","author":"Yi","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.drup.2025.101273_bib171","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/1078-0432.CCR-17-3725","article-title":"The IGF2\/IR\/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma","volume":"24","author":"Vaquero","year":"2018","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib172","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41419-019-1581-6","article-title":"Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1\/ER\u03b2\/Bcl-2 signalling","volume":"10","author":"Long","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101273_bib173","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183366","article-title":"Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy","volume":"134","author":"Song","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2025.101273_bib174","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12943-022-01501-3","article-title":"circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF\/STAT3 axis","volume":"21","author":"Hu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib175","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mc.23668","article-title":"Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1\u03b1\/miR-21 axis under hypoxic conditions in pancreatic cancer","volume":"63","author":"Deng","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.drup.2025.101273_bib176","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2008.12.004","article-title":"PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment","volume":"15","author":"Crawford","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib177","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.canlet.2020.10.032","article-title":"Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells","volume":"497","author":"Li","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib178","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1038\/s41467-024-49189-x","article-title":"TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer","volume":"15","author":"Anandhan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib179","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s11010-022-04436-x","article-title":"CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer","volume":"477","author":"Yang","year":"2022","journal-title":"Mol. Cell. Biochem"},{"key":"10.1016\/j.drup.2025.101273_bib180","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.1424355112","article-title":"COX\/mPGES-1\/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset","volume":"112","author":"Larsson","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2025.101273_bib181","first-page":"11101","article-title":"Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor-stroma drug targeting","volume":"34","author":"Kock","year":"2020","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.drup.2025.101273_bib182","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","article-title":"Cancer associated-fibroblast-derived exosomes in cancer progression","volume":"20","author":"Li","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib183","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12943-024-02106-8","article-title":"Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib184","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/hed.27155","article-title":"Loss of exosomal miR-34c-5p in cancer-associated fibroblast for the maintenance of stem-like phenotypes of laryngeal cancer cells","volume":"44","author":"Wang","year":"2022","journal-title":"Head. Neck"},{"key":"10.1016\/j.drup.2025.101273_bib185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3349\/ymj.2022.63.3.229","article-title":"MEG3 LncRNA from Exosomes Released from Cancer-associated Fibroblasts Enhances Cisplatin Chemoresistance in SCLC via a MiR-15a-5p\/CCNE1 Axis","volume":"63","author":"Sun","year":"2022","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.drup.2025.101273_bib186","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/IJN.S271976","article-title":"CAFs-derived exosomal miRNA-130a confers cisplatin resistance of NSCLC Cells through PUM2-dependent packaging","volume":"16","author":"Zhang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.drup.2025.101273_bib187","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.989","article-title":"Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN\/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer","volume":"12","author":"Shi","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib188","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.3390\/cancers13236005","article-title":"The MEK\/ERK\/miR-21 signaling is critical in osimertinib resistance in EGFR-mutant non-small cell lung cancer cells","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2025.101273_bib189","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2021.06.009","article-title":"Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6\/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma","volume":"518","author":"Zhao","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib190","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10142-024-01447-3","article-title":"The mechanism of MMP14-positive tumor-associated fibroblast subsets in inhibiting PD-1 immunotherapy for esophageal cancer through exosomal tsRNA-10522","volume":"24","author":"Wang","year":"2024","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.drup.2025.101273_bib191","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","article-title":"CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib192","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/jcmm.15765","article-title":"Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2\/HEPH","volume":"25","author":"Zhang","year":"2021","journal-title":"axis. J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2025.101273_bib193","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.7150\/thno.25541","article-title":"Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19","volume":"8","author":"Ren","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101273_bib194","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41417-023-00700-4","article-title":"Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p\/CRKL axis","volume":"31","author":"Hu","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.drup.2025.101273_bib195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-019-1019-x","article-title":"CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer","volume":"18","author":"Hu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib196","first-page":"330","article-title":"CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer","volume":"56","author":"Zhu","year":"2024","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"10.1016\/j.drup.2025.101273_bib197","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ijc.32608","article-title":"Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells","volume":"146","author":"Deng","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113266","article-title":"CAFs-secreted exosomal cricN4BP2L2 promoted colorectal cancer stemness and chemoresistance by interacting with EIF4A3","volume":"418","author":"Qu","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.drup.2025.101273_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111543","article-title":"Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer","volume":"383","author":"Fang","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.drup.2025.101273_bib200","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"68","author":"Qi","year":"2023","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2025.101273_bib201","first-page":"324","article-title":"Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2025.101273_bib202","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cas.16014","article-title":"Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN\/AKT and SOCS6\/STAT3 pathways","volume":"115","author":"Sun","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.drup.2025.101273_bib203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/jog.14418","article-title":"Exosomal lncRNA UCA1 from cancer-associated fibroblasts enhances chemoresistance in vulvar squamous cell carcinoma cells","volume":"47","author":"Gao","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.drup.2025.101273_bib204","first-page":"282","article-title":"Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2025.101273_bib205","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41388-024-03057-6","article-title":"Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer","volume":"43","author":"Zhao","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib206","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/s12276-020-0431-z","article-title":"Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-\u03b2 signaling pathway","volume":"52","author":"Shan","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.drup.2025.101273_bib207","doi-asserted-by":"crossref","first-page":"8515","DOI":"10.1073\/pnas.1910952117","article-title":"Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance","volume":"117","author":"Haldar","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2025.101273_bib208","doi-asserted-by":"crossref","first-page":"E9066","DOI":"10.1073\/pnas.1704862114","article-title":"Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer","volume":"114","author":"Sansone","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2025.101273_bib209","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","article-title":"Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance","volume":"83","author":"Zhuang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13402-020-00500-0","article-title":"Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt\/\u03b2-catenin pathway and upregulating PTEN","volume":"44","author":"Shan","year":"2021","journal-title":"Cell. Oncol. Dordr. Neth."},{"key":"10.1016\/j.drup.2025.101273_bib211","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/abbs\/gmab023","article-title":"Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p\/ABCB1 axis","volume":"53","author":"Luo","year":"2021","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.drup.2025.101273_bib212","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1038\/s41388-021-01829-y","article-title":"Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma","volume":"40","author":"Kunou","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib213","doi-asserted-by":"crossref","first-page":"13220","DOI":"10.18632\/aging.103429","article-title":"Cancer-associated fibroblasts-derived gamma-glutamyltransferase 5 promotes tumor growth and drug resistance in lung adenocarcinoma","volume":"12","author":"Wei","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.drup.2025.101273_bib214","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.immuni.2022.07.001","article-title":"Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment","volume":"55","author":"Gong","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.drup.2025.101273_bib215","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1158\/0008-5472.CAN-21-0914","article-title":"Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer","volume":"82","author":"Ippolito","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drup.2025.101273_bib217","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-030-21735-8_9","article-title":"Targeting the COX\/mPGES-1\/PGE2 pathway in neuroblastoma","volume":"1161","author":"Larsson","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drup.2025.101273_bib218","first-page":"258","article-title":"Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells","volume":"38","author":"Hwang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2025.101273_bib219","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/atm-20-4843","article-title":"Cancer-associated fibroblasts promote the migration and invasion of gastric cancer cells via activating IL-17a\/JAK2\/STAT3 signaling","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib220","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-05169-z","article-title":"Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome","volume":"610","author":"Su","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101273_bib221","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1158\/2326-6066.CIR-18-0086","article-title":"Stromal fibroblasts mediate anti-PD-1 resistance via MMP-9 and dictate TGF\u03b2 inhibitor sequencing in melanoma","volume":"6","author":"Zhao","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.drup.2025.101273_bib222","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.7150\/thno.73714","article-title":"Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma","volume":"12","author":"Huang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101273_bib223","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41368-023-00236-1","article-title":"Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK\/p-paxillin\/YAP signaling","volume":"15","author":"Liu","year":"2023","journal-title":"Int. J. Oral. Sci."},{"key":"10.1016\/j.drup.2025.101273_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111462","article-title":"CAF-secreted LOX promotes PD-L1 expression via histone Lactylation and regulates tumor EMT through TGF\u03b2\/IGF1 signaling in gastric Cancer","volume":"124","author":"Li","year":"2024","journal-title":"Cell. Signal"},{"key":"10.1016\/j.drup.2025.101273_bib225","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib226","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1101\/gad.17276711","article-title":"Control of the senescence-associated secretory phenotype by NF-\u03baB promotes senescence and enhances chemosensitivity","volume":"25","author":"Chien","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.drup.2025.101273_bib227","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","article-title":"Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer","volume":"14","author":"Belle","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101273_bib228","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature17392","article-title":"sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance","volume":"532","author":"Kaur","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101273_bib229","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/0008-5472.CAN-24-0086","article-title":"Fibroblasts in the aged pancreas drive pancreatic cancer progression","volume":"84","author":"Zabransky","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122631","article-title":"Targeting cellular senescence as a therapeutic vulnerability in gastric cancer","volume":"346","author":"Geng","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.drup.2025.101273_bib231","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2024","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2025.101273_bib232","doi-asserted-by":"crossref","first-page":"10728","DOI":"10.18632\/oncotarget.3828","article-title":"Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells","volume":"6","author":"Peiris-Pag\u00e8s","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101273_bib233","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/15548627.2022.2090693","article-title":"Tumor-derived CTF1 (cardiotrophin 1) is a critical mediator of stroma-assisted and autophagy-dependent breast cancer cell migration, invasion and metastasis","volume":"19","author":"Akkoc","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2025.101273_bib234","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.4161\/cc.9.17.12928","article-title":"Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NF\u03baB activation in the tumor stromal microenvironment","volume":"9","author":"Martinez-Outschoorn","year":"2010","journal-title":"Cell Cycle Georget. Tex."},{"key":"10.1016\/j.drup.2025.101273_bib235","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopha.2017.11.024","article-title":"Cancer-associated \ufb01broblasts confer cisplatin resistance of tongue cancer via autophagy activation","volume":"97","author":"Liao","year":"2018","journal-title":"Biomed. Pharm. Biomedecine Pharm."},{"key":"10.1016\/j.drup.2025.101273_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113195","article-title":"TGF-\u03b21 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation","volume":"417","author":"Jena","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.drup.2025.101273_bib237","first-page":"171","article-title":"The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer","volume":"38","author":"Yan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2025.101273_bib238","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/leu.2015.289","article-title":"Halting pro-survival autophagy by TGF\u03b2 inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients","volume":"30","author":"Frassanito","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101273_bib239","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1158\/0008-5472.CAN-17-1077","article-title":"Secretory autophagy in cancer-associated fibroblasts promotes head and neck cancer progression and offers a novel therapeutic target","volume":"77","author":"New","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib240","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/15548627.2019.1659608","article-title":"De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy","volume":"16","author":"Andrejeva","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2025.101273_bib241","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","article-title":"CAF-induced physical constraints controlling T cell state and localization in solid tumours","volume":"24","author":"Arpinati","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib242","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1158\/0008-5472.CAN-22-0435","article-title":"ATM regulates differentiation of myofibroblastic cancer-associated fibroblasts and can be targeted to overcome immunotherapy resistance","volume":"82","author":"Mellone","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib243","doi-asserted-by":"crossref","first-page":"eabc8346","DOI":"10.1126\/sciadv.abc8346","article-title":"Laminin \u03b32-mediating T cell exclusion attenuates response to anti-PD-1 therapy","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2025.101273_bib244","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","article-title":"Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells","volume":"9","author":"Lakins","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib245","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2019.00847","article-title":"Human pancreatic carcinoma-associated fibroblasts promote expression of co-inhibitory markers on CD4+ and CD8+ T-Cells","volume":"10","author":"Gorchs","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2025.101273_bib246","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1186\/s12885-021-08669-9","article-title":"Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214\/PD-L1 axis","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib247","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","article-title":"Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer","volume":"208","author":"De Monte","year":"2011","journal-title":"J. Exp. Med."},{"issue":"e122375","key":"10.1016\/j.drup.2025.101273_bib248","article-title":"Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis","volume":"3","author":"Andersson","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.drup.2025.101273_bib249","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41388-022-02540-2","article-title":"CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype","volume":"42","author":"Zeng","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib250","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/onc.2017.65","article-title":"Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of chitinase 3-like 1","volume":"36","author":"Cohen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib251","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.7150\/thno.99046","article-title":"DAB2 + macrophages support FAP + fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer","volume":"14","author":"Long","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101273_bib252","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1038\/s41467-024-53233-1","article-title":"Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib253","doi-asserted-by":"crossref","first-page":"39541","DOI":"10.1038\/srep39541","article-title":"Estrogen-induced SDF-1\u03b1 production promotes the progression of ER-negative breast cancer via the accumulation of MDSCs in the tumor microenvironment","volume":"6","author":"Ouyang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2025.101273_bib254","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.32099","article-title":"CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase","volume":"75","author":"Y","year":"2022","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.drup.2025.101273_bib255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.drup.2025.101273_bib256","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78921","article-title":"Neutrophil-mediated fibroblast-tumor cell il-6\/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: a hybrid clinical-preclinical study","volume":"11","author":"de Castro Silva","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.drup.2025.101273_bib257","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gutjnl-2020-322924","article-title":"Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.drup.2025.101273_bib258","doi-asserted-by":"crossref","unstructured":"Herzog, B.H. et al. Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancer. Sci. Transl. Med. 15, eadh8005 (2023).","DOI":"10.1126\/scitranslmed.adh8005"},{"key":"10.1016\/j.drup.2025.101273_bib259","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1182\/blood.2021012811","article-title":"Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma","volume":"139","author":"Sakemura","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101273_bib260","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41416-022-02106-9","article-title":"Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP\/TAZ-hedgehog signalling axis in pancreatic cancer","volume":"128","author":"Liu","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib261","article-title":"Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance","volume":"53","author":"Erin","year":"2020","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2025.101273_bib262","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s13402-021-00615-y","article-title":"Correction to: downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt\/\u03b2-catenin pathway and upregulating PTEN","volume":"44","author":"Shan","year":"2021","journal-title":"Cell. Oncol. Dordr. Neth."},{"key":"10.1016\/j.drup.2025.101273_bib263","first-page":"5641","article-title":"Tenascin C in pancreatic cancer-associated fibroblasts enhances epithelial mesenchymal transition and is associated with resistance to immune checkpoint inhibitor","volume":"13","author":"Furuhashi","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib264","first-page":"170","article-title":"Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP","volume":"38","author":"Sun","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2025.101273_bib265","first-page":"231","article-title":"HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK\/ERK and PI3K\/AKT signaling pathways","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2025.101273_bib266","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.redox.2017.08.015","article-title":"Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis","volume":"14","author":"Masaldan","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.drup.2025.101273_bib267","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41419-024-06671-0","article-title":"Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101273_bib268","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101273_bib269","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12943-022-01682-x","article-title":"Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis","volume":"21","author":"Nallasamy","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib270","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","article-title":"Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1-CD44 Axis","volume":"161","author":"Nallasamy","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2025.101273_bib271","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114800","article-title":"Identification of INFG\/STAT1\/NOTCH3 as \u03b3-Mangostin\u2019s potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer","volume":"163","author":"Lawal","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.drup.2025.101273_bib272","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/s41467-018-05220-6","article-title":"Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer","volume":"9","author":"Cazet","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib273","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2020.08.030","article-title":"Small extracellular vesicle-bound vascular endothelial growth factor secreted by carcinoma-associated fibroblasts promotes angiogenesis in a bevacizumab-resistant manner","volume":"492","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib274","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ebiom.2018.05.008","article-title":"Inhibition of microsomal prostaglandin E synthase-1 in cancer-associated fibroblasts suppresses neuroblastoma tumor growth","volume":"32","author":"Kock","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drup.2025.101273_bib275","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.7150\/thno.74753","article-title":"Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer","volume":"12","author":"Zeng","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101273_bib276","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1172\/JCI95200","article-title":"Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance","volume":"128","author":"Leung","year":"2018","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2025.101273_bib277","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2018.12.004","article-title":"Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma","volume":"70","author":"Cadamuro","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drup.2025.101273_bib278","doi-asserted-by":"crossref","first-page":"369","DOI":"10.14336\/AD.2023.0420","article-title":"Cancer-associated fibroblasts promote lymphatic metastasis in cholangiocarcinoma via the PDGF-BB\/PDGFR-\u03b2 mediated paracrine signaling network","volume":"15","author":"Yan","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.drup.2025.101273_bib279","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2015.03.008","article-title":"Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin \u03b21\/FAK signaling","volume":"27","author":"Hirata","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib280","first-page":"99","article-title":"Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation","volume":"37","author":"Wu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2025.101273_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155709","article-title":"TGF-beta signaling in cancer radiotherapy","volume":"148","author":"Wang","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.drup.2025.101273_bib282","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1172\/JCI94624","article-title":"Fibroblast-specific inhibition of TGF-\u03b21 signaling attenuates lung and tumor fibrosis","volume":"127","author":"Wei","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2025.101273_bib283","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tcb.2024.04.009","article-title":"Biomolecular condensates: hubs of Hippo-YAP\/TAZ signaling in cancer","volume":"34","author":"Kiang","year":"2024","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.drup.2025.101273_bib284","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1038\/s41467-023-42382-4","article-title":"Cancer-associated fibroblasts actively compress cancer cells and modulate mechanotransduction","volume":"14","author":"Barbazan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib285","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41388-024-02953-1","article-title":"YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression","volume":"43","author":"Xiao","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib286","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.matbio.2023.05.006","article-title":"Matrix stiffening facilitates the collective invasion of breast cancer through the periostin-integrin mechanotransduction pathway","volume":"121","author":"Wu","year":"2023","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.drup.2025.101273_bib287","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.7150\/thno.94207","article-title":"Cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-STAT3 signaling","volume":"14","author":"Jin","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101273_bib288","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.neo.2016.09.003","article-title":"Tissue transglutaminase activates cancer-associated fibroblasts and contributes to gemcitabine resistance in pancreatic cancer","volume":"18","author":"Lee","year":"2016","journal-title":"Neoplasia N. Y. N."},{"key":"10.1016\/j.drup.2025.101273_bib289","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","article-title":"Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer","volume":"57","author":"Yan","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drup.2025.101273_bib290","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1158\/0008-5472.CAN-19-3803","article-title":"Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 induces FAK-YAP activation by stabilizing \u03b21 integrin, enhancing drug resistance","volume":"80","author":"Uchihara","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib291","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13058-015-0579-y","volume":"17","author":"Yuan","year":"2015","journal-title":"Breast Cancer Res. BCR"},{"key":"10.1016\/j.drup.2025.101273_bib292","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113270","article-title":"Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101273_bib293","article-title":"CAF-secreted COL5A2 activates the PI3K\/AKT pathway to mediate erlotinib resistance in head and neck squamous cell carcinoma","author":"Guo","year":"2024","journal-title":"Oral. Dis."},{"issue":"e146987","key":"10.1016\/j.drup.2025.101273_bib294","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"Bhattacharjee","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2025.101273_bib295","article-title":"Cancer-associated fibroblasts derived fibronectin extra domain A promotes sorafenib resistance in hepatocellular carcinoma cells by activating SHMT1","volume":"11","author":"Dong","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.drup.2025.101273_bib296","article-title":"Unlocking the potential: targeting metabolic pathways in the tumor microenvironment for Cancer therapy","volume":"1879","author":"Jia","year":"2024","journal-title":"Biochim. Biophys. Acta BBA Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib297","doi-asserted-by":"crossref","first-page":"61890","DOI":"10.18632\/oncotarget.11301","article-title":"Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells","volume":"7","author":"Ippolito","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101273_bib298","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112876","article-title":"Myc-mediated inhibition of HIF1a degradation promotes M2 macrophage polarization and impairs CD8 T cell function through lactic acid secretion in ovarian cancer","volume":"141","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.drup.2025.101273_bib299","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2018.08.006","article-title":"Increased lactate secretion by cancer cells sustains non-cell-autonomous adaptive resistance to met and egfr targeted therapies","volume":"28","author":"Apicella","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.drup.2025.101273_bib300","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle Georget. Tex."},{"key":"10.1016\/j.drup.2025.101273_bib301","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1620\/tjem.2024.J041","article-title":"HJURP derived from cancer-associated fibroblasts promotes glutamine metabolism to induce resistance to doxorubicin in ovarian cancer","volume":"264","author":"Lan","year":"2024","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.drup.2025.101273_bib302","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cmet.2018.09.012","article-title":"Tumor-stroma mechanics coordinate amino acid availability to sustain tumor growth and malignancy","volume":"29","author":"Bertero","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.drup.2025.101273_bib303","doi-asserted-by":"crossref","first-page":"27584","DOI":"10.18632\/oncotarget.8488","article-title":"Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2\/kynurenine axis","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101273_bib304","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1186\/s12885-022-09877-7","article-title":"Cancer-associated fibroblasts strengthen cell proliferation and EGFR TKIs resistance through aryl hydrocarbon receptor dependent signals in non-small cell lung cancer","volume":"22","author":"Feng","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib305","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1158\/0008-5472.CAN-20-2496","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition","volume":"81","author":"Sharbeen","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114972","article-title":"Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment","volume":"43","author":"Han","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101273_bib307","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12964-019-0505-5","article-title":"Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis","volume":"18","author":"Neuwirt","year":"2020","journal-title":"Cell Commun. Signal. CCS"},{"key":"10.1016\/j.drup.2025.101273_bib308","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-024-10186-7","article-title":"Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy","volume":"43","author":"Guo","year":"2024","journal-title":"Cancer Metastas.. Rev."},{"key":"10.1016\/j.drup.2025.101273_bib309","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","article-title":"Embracing cancer complexity: hallmarks of systemic disease","volume":"187","author":"Swanton","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101273_bib310","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108522","article-title":"Cancer metastasis: molecular mechanisms and clinical perspectives","volume":"250","author":"Khan","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drup.2025.101273_bib311","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-02189-8","article-title":"Tumor microenvironment differences between primary tumor and brain metastases","volume":"18","author":"Cacho-D\u00edaz","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib312","article-title":"Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: mechanisms and therapeutic prospects","author":"Liu","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.drup.2025.101273_bib313","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1101","article-title":"Single-cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastases","volume":"12","author":"Sun","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib314","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","article-title":"The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib315","article-title":"The single-cell landscape of intratumoral heterogeneity and the immunosuppressive microenvironment in liver and brain metastases of breast cancer","volume":"10","author":"Zou","year":"2023","journal-title":"Adv. Sci. Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.drup.2025.101273_bib316","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41467-019-14134-w","article-title":"Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms","volume":"11","author":"Pelon","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib317","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-024-03319-w","article-title":"Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcoma","volume":"22","author":"Liu","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.drup.2025.101273_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217180","article-title":"Single-cell RNA sequencing of OSCC primary tumors and lymph nodes reveals distinct origin and phenotype of fibroblasts","volume":"600","author":"Zhang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib319","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40164-023-00407-0","article-title":"ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer","volume":"12","author":"Xin","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101273_bib320","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7150\/jca.80115","article-title":"Different expression and clinical implications of cancer-associated fibroblast (CAF) markers in brain metastases","volume":"14","author":"Akanda","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib321","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2356942","article-title":"HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis","volume":"13","author":"You","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.drup.2025.101273_bib322","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1605","article-title":"Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non-small-cell lung cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib323","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2322688121","article-title":"Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies","volume":"121","author":"Goyette","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drup.2025.101273_bib324","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113463","article-title":"Brain metastasis-associated fibroblasts secrete fucosylated PVR\/CD155 that induces breast cancer invasion","volume":"42","author":"Adhikari","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101273_bib325","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s42003-023-05124-2","article-title":"Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment","volume":"6","author":"Song","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.drup.2025.101273_bib326","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13045-021-01203-1","article-title":"Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma","volume":"14","author":"Pan","year":"2021","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101273_bib327","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60745","article-title":"Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity","volume":"10","author":"Shani","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.drup.2025.101273_bib328","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41467-020-15188-x","article-title":"Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs","volume":"11","author":"Pein","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib329","doi-asserted-by":"crossref","DOI":"10.1002\/cac2.12608","article-title":"Tryptophan 2,3-dioxygenase-positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine-mediated ferroptosis resistance of metastatic cells and T cell dysfunction","author":"Liu","year":"2024","journal-title":"Cancer Commun. Lond. Engl."},{"key":"10.1016\/j.drup.2025.101273_bib330","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.7150\/thno.51245","article-title":"H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101273_bib331","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3390\/cancers7040872","article-title":"The mesothelial origin of carcinoma associated-fibroblasts in peritoneal metastasis","volume":"7","author":"Rynne-Vidal","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2025.101273_bib332","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4281","article-title":"Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis","volume":"231","author":"Sandoval","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.drup.2025.101273_bib333","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41416-024-02717-4","article-title":"Metastasis-associated fibroblasts in peritoneal surface malignancies","volume":"131","author":"Ramos","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib334","doi-asserted-by":"crossref","first-page":"42262","DOI":"10.18632\/oncotarget.15040","article-title":"Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101273_bib335","article-title":"CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases","author":"Li","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.drup.2025.101273_bib336","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108779","article-title":"Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination","volume":"34","author":"Yasuda","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2025.101273_bib337","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.surg.2017.07.027","article-title":"Cancer stemness in bone marrow micrometastases of human breast cancer","volume":"163","author":"Kuo","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.drup.2025.101273_bib338","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1038\/onc.2016.436","article-title":"Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche","volume":"36","author":"Shahriari","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101273_bib339","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1158\/1541-7786.MCR-11-0506","article-title":"Loss of TGF-\u03b2 responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic\/osteolytic bone lesions","volume":"10","author":"Li","year":"2012","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.drup.2025.101273_bib340","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2018.01.018","article-title":"Loss of TGF-\u03b2 signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis","volume":"418","author":"Meng","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib341","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.7150\/thno.72853","article-title":"The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases","volume":"12","author":"Giguelay","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101273_bib342","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1038\/s41467-023-40727-7","article-title":"Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib343","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","article-title":"Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal cancer","volume":"37","author":"Shen","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib344","article-title":"FGF19-induced inflammatory CAF promoted neutrophil extracellular trap formation in the liver metastasis of colorectal cancer","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci. Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.drup.2025.101273_bib345","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1158\/1078-0432.CCR-19-1268","article-title":"Metastatic breast carcinoma-associated fibroblasts have enhanced protumorigenic properties related to increased IGF2 expression","volume":"25","author":"Gui","year":"2019","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib346","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1038\/s41467-024-47949-3","article-title":"Macrophage-fibroblast JAK\/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer","volume":"15","author":"Raymant","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib347","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-24-3918","article-title":"177Lu-LNC1004 radioligand therapy in patients with end-stage metastatic cancers: a single-center, single-arm, phase ii study","volume":"31","author":"Fu","year":"2025","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib348","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/1078-0432.CCR-22-1432","article-title":"Safety and efficacy of 90Y-FAPI-46 radioligand therapy in patients with advanced sarcoma and other cancer entities","volume":"28","author":"Fendler","year":"2022","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib349","first-page":"1952","article-title":"FAP and PSMA expression by immunohistochemistry and PET imaging in castration-resistant prostate cancer: a translational pilot","volume":"65","author":"Huang","year":"2024","journal-title":"Study J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294564","article-title":"Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: a phase 2, multicenter, single arm, open label non-randomized study protocol","volume":"18","author":"Karbhari","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.drup.2025.101273_bib351","first-page":"727","article-title":"Initial clinical experience with 90Y-FAPI-46 radioligand therapy for advanced-stage solid tumors: a case series of 9 patients","volume":"63","author":"Ferdinandus","year":"2022","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib352","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12885-022-09272-2","article-title":"Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I\/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma","volume":"22","author":"Mizutani","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib353","article-title":"Targeting FAK improves the tumor uptake of antibody-drug conjugates to strengthen the anti-cancer responses","volume":"28","author":"Zhang","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.drup.2025.101273_bib354","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2016.02.1226","article-title":"The 12-month analysis from basal cell carcinoma outcomes with LDE225 Treatment (BOLT): a phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma","volume":"75","author":"Dummer","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.drup.2025.101273_bib355","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1158\/1078-0432.CCR-13-1710","article-title":"A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors","volume":"20","author":"Rodon","year":"2014","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib356","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/s41467-018-05220-6","article-title":"Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer","volume":"9","author":"Cazet","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101273_bib357","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccell.2025.02.001","article-title":"FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma","volume":"43","author":"Lubrano","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101273_bib358","doi-asserted-by":"crossref","first-page":"eado2402","DOI":"10.1126\/scitranslmed.ado2402","article-title":"Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy","volume":"16","author":"Liu","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib359","article-title":"Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC","volume":"218","author":"M","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drup.2025.101273_bib360","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-Cell Exclusion from Tumors","volume":"80","author":"Ford","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101273_bib361","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.apsb.2020.10.022","article-title":"Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drup.2025.101273_bib362","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123437","article-title":"Dual inhibition of oxidative phosphorylation and glycolysis using a hyaluronic acid nanoparticle NOX inhibitor enhanced response to radiotherapy in colorectal cancer","volume":"323","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2025.101273_bib363","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1073\/pnas.1815515116","article-title":"Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drup.2025.101273_bib364","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217287","article-title":"Pirfenidone antagonizes TGF-\u03b21-mediated gabapentin resistance via reversal of desmoplasia and the \u2018cold\u2019 microenvironment in pancreatic cancer","volume":"605","author":"Zhang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2025.101273_bib365","article-title":"Biomimetic nanoplatform for dual-targeted clearance of activated and senescent cancer-associated fibroblasts to improve radiation resistance in breast cancer","volume":"20","author":"Jian","year":"2024","journal-title":"Small Weinh. Bergstr. Ger."},{"key":"10.1016\/j.drup.2025.101273_bib366","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009327","article-title":"Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade","volume":"12","author":"Mei","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib367","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2022.07.076","article-title":"Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy resistance in pancreatic cancer","volume":"163","author":"J","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2025.101273_bib368","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.7150\/thno.68972","article-title":"FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts","volume":"12","author":"Wu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101273_bib369","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/cai2.39","article-title":"PD-L1 blockade by immune checkpoint inhibitors impairs sensitivity to osimertinib in EGFR-mutant non-small cell lung cancer cells","volume":"1","author":"Sun","year":"2022","journal-title":"Cancer Innov."},{"key":"10.1016\/j.drup.2025.101273_bib370","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12951-024-02452-1","article-title":"An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments","volume":"22","author":"Xue","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drup.2025.101273_bib371","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","article-title":"Engineered exosomes from different sources for cancer-targeted therapy","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101273_bib372","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2021.03.026","article-title":"3D bioprinting of engineered breast cancer constructs for personalized and targeted cancer therapy","volume":"333","author":"Sharifi","year":"2021","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.drup.2025.101273_bib373","article-title":"Dendritic polymer-based nanomedicines remodel the tumor stroma: improve drug penetration and enhance antitumor immune response","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater. Deerfield Beach Fla"},{"key":"10.1016\/j.drup.2025.101273_bib374","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.actbio.2021.09.003","article-title":"Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis","volume":"135","author":"Hu","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.drup.2025.101273_bib375","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2016.09.014","article-title":"Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system","volume":"241","author":"Chen","year":"2016","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.drup.2025.101273_bib376","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12951-021-01172-0","article-title":"Irinotecan\/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.drup.2025.101273_bib377","first-page":"1423","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.drup.2025.101273_bib378","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101273_bib379","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.102","article-title":"A comprehensive review of 3D cancer models for drug screening and translational research","volume":"3","author":"Sharma","year":"2024","journal-title":"Cancer Innov."},{"key":"10.1016\/j.drup.2025.101273_bib380","first-page":"16296","article-title":"Developing a palladium(II) agent to overcome multidrug resistance and metastasis of liver tumor by targeted multiacting on tumor cell, inactivating cancer-associated fibroblast and activating","volume":"67","author":"Jiang","year":"2024","journal-title":"Immune Response J. Med. Chem."},{"key":"10.1016\/j.drup.2025.101273_bib381","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101273_bib382","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:25:15Z","timestamp":1762374315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":382,"alternative-id":["S1368764625000767"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101273","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101273"}}